Mutation homozygous class I or II (N) |
41 (93.1) |
Pancreatic insufficient (N) |
43 (95.6) |
Male (N) |
20 (44.4) |
Caucasian (N) |
43 (95.6) |
Hospital Admission prior to iPFT (N) |
20 (44.4) |
Age at iPFT testing in months (Mean, SD) |
15.8 (3.16) |
WFA z-score at time of iPFT (Mean, SD) |
-0.67 (0.93) |
Height z-score at time of iPFT (Mean, SD) |
-0.4 (0.98) |
WFL z-score at time of iPFT (Mean, SD) |
-0.01 (0.83) |
Second hand smoke exposure (N) |
15 (33.3) |
Oral corticosteroid treatment in first year of life (N) |
11
(24.4) |
Oral antibiotics in first year of life (N) |
41 (91.1) |
Number oral antibiotics before iPFT (Median, range) |
2
(0-10) |
MSSA positive culture* (N) |
30 (66.7) |
MRSA positive culture* (N) |
6 (13.3) |
Pseudomonas aeruginosa positive culture* (N) |
16
(35.6) |
Stenotrophomonas maltophilia positive culture* (N) |
8
(17.8) |
WFA z-score at 6 months of age (Mean, SD) |
-0.72 (1.1) |
WFL z-score at 6 months of age (Mean, SD) |
-0.51 (1.03) |